Dr Karanam Ashok Kumar is one of the leading hemato-oncologists in Hyderabad. He is currently working as a Consultant Hematologist & BMT specialist at Yashoda Hospitals, Somajiguda, Hyderabad.
Dr Ashok Kumar is recognised as one of the most experienced Bone Marrow Transplant (BMT) physicians in the region. His clinical expertise encompasses the treatment of complex hematological disorders including Leukemia, Myelodysplastic Syndromes, Lymphomas, Multiple Myeloma, Amyloidosis, Bone Marrow/Stem Cell Transplantation, Thalassemia, Sickle Cell Anemia, and Aplastic Anemia. He has successfully performed over 400 transplants in both adult and paediatric patients.
Educational Qualifications
2005: MBBS, S.V. Medical College, Tirupati.
2009 to 2012: DNB, Nizam's Institute of Medical Sciences, Hyderabad.
2013 to 2016: DM, Nizam's Institute of Medical Sciences, Hyderabad.
2018 to 2019: Post-Doctoral Fellowship, Christian Medical College, Vellore.
Experience
2016 to 2018: Assistant Professor, Nizam's Institute of Medical Sciences.
August 2019 to March 2020: Consultant Haemato-Oncologist & BMT Specialist, Care Hospitals.
2020 to 2025: Consultant Haemato-Oncologist & BMT Specialist.
2021: Associate Professor, Mehdi Nawaj Jung Regional Cancer Center.
July 2025 to Present: Senior Consultant Haemato-Oncologist & BMT Specialist, Yashoda Hospitals, Somajiguda.
Services offered
Hematology (Adult & Pediatric)
Diagnosis and management of anemia and complex blood disorders in children and adults
Evaluation and treatment of bleeding and clotting disorders, including hemophilia and platelet disorders
Management of thalassemia and other inherited hematological conditions
Treatment of aplastic anemia
Evaluation of abnormal blood counts, lymphadenopathy, and bone marrow disorders
Management of myelodysplastic syndromes (MDS) and other hematological abnormalities
Haemato-oncology:
Diagnosis and treatment of acute and chronic leukemias in pediatric and adult patients
Management of Hodgkin and Non-Hodgkin lymphomas
Treatment of multiple myeloma and plasma cell disorders
Comprehensive care for pediatric blood cancers and hematological malignancies
Multidisciplinary cancer care with personalized treatment planning
Bone Marrow Transplant (BMT)
Autologous stem cell transplantation for selected hematological malignancies
Allogeneic bone marrow transplantation using matched donors
Haploidentical (half-matched donor) transplants
Pre-transplant evaluation for both pediatric and adult recipients and donors
Stem cell harvesting and transplant coordination
Post-transplant monitoring and long-term follow-up care
Management of transplant complications, including graft-versus-host disease (GVHD)
Indian Society of Blood and Marrow Transplantation
Asia Pacific Society of Blood and Marrow Transplantation
Management of Hemato-Oncology Children During COVID-19 Crisis Ranjit Kumar C.S., Raghu K. Sukumaran, Anil Aribandi, Ashok Kumar K., Arun Kumar Lingutla, Krishnamani K.V. International Journal of Research in Pharmaceutical Sciences. Vol. 11, SPL 1 (2020).
Managing Metastatic Renal Cell Carcinoma: Challenges, Pitfalls, and Outcomes in the Real World Kumar K.A., Sadashivudu G., Krishnamani K.V., Linga V.G., Maddali L.S., Digumarti R.R. Indian Journal of Medical and Paediatric Oncology. 2016;37:260–264.
Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: 8 Years’ Experience from a Tertiary Care Center in India Danthala M., Gundeti S., Maddali L.S., Pillai A., Puligundla K.C., Adusumilli R.P. South Asian Journal of Cancer. 2016;5:176–178.
Thiopurine Methyltransferase Polymorphisms in Children with Acute Lymphoblastic Leukemia Linga V.G., Patchva D.B., Mallavarapu K.M., Tulasi V., Kalpathi K.I., Pillai A., Gundeti S., Rajappa S.J., Digumarti R. Indian Journal of Medical and Paediatric Oncology. 2014;35(4):Oct–Dec.
Fanconi Syndrome Following Honeybee Stings – A Case Report Rapur Ram, Gudithi Swarnalatha, Karanam Ashok Kumar, Hasaagrahara Radhakrishna Madhuri, Kaligotla Venkata Dakshinamurthy International Urology and Nephrology. 2012;44:315–318.
Generic Imatinib in Chronic Myeloid Leukemia: Survival of the Cheapest Danthala M., Gundeti S., Kuruva S.P., Puligundla K.C., Adusumilli P., Karnam A.P., Bala S., Konatam M.L., Maddali L.S., Digumarti R.R. Clinical Lymphoma, Myeloma & Leukemia. 2017 May 10.
The Role of Mutation Testing in Patients with CML-CP After Imatinib Failure and Their Outcomes After Treatment Modification: A Single Institutional Experience Over 13 Years Chaitanya P.K., Kumar K.A., Stalin B., Sadashivudu G., Srinivas M.L. Indian Journal of Medical and Paediatric Oncology. 2017;38:328–333.
Clinicopathological Features and Outcomes in Primary Central Nervous System Lymphoma: A 10-Year Experience Puligundla C.K., Bala S., Karnam A.K., Gundeti S., Paul T.R., Uppin M.S., et al. Indian Journal of Medical and Paediatric Oncology. 2017;38:478–482.
Impact of Cytogenetics on Outcomes in Pediatric Acute Lymphoblastic Leukemia Chennamaneni R., Gundeti S., Konatam M.L., Bala S., Kumar A., Maddali L.S. South Asian Journal of Cancer. 2018 Oct–Dec;7(4):263–266.
Clinicopathological Features, Treatment and Survival Outcomes of Synovial Sarcoma Kuruva S.P., Bala S., Konatam M.L., Karnam A.K., Maddali L.S., Gundeti S. South Asian Journal of Cancer. 2018 Oct–Dec;7(4):270–272.
Pattern of Metastases and Their Impact on Outcomes in Stage IV Non-Small Cell Lung Cancer: An Institutional Experience from South India Stalin B., Gundeti S., Kumar A., Maddali L.S., Kandula R., Digumarti R. Medical Oncology, Nizam’s Institute of Medical Sciences, Hyderabad & Homi Bhabha Cancer Hospital and Research Center, Visakhapatnam.
Posters/Papers/Oral Presentations
International Conferences
Impact of COVID-19 and Lockdown on Adherence to Treatment Schedule Among Cancer Patients K. Kalpathi, D. Darshini, A. Aribandi, A.K. Pillai, R. Kumar, A.K. Lingutla, M. Krishnamani, K. Mathi Presented at ESMO Asia Virtual Congress, Singapore, Nov 2020.
Challenges Faced by Cancer Patients During the COVID-19 Pandemic M. Krishnamani, R. Kishore, P. Gundlapally, A.K. Pillai, R. Kumar, A.K. Lingutla, A. Aribandi, K. Mathi Presented at ESMO Asia Virtual Congress, Singapore, Nov 2020.
Mutation Analysis and Treatment Outcomes of BCR-ABL Tyrosine Kinase Domains in CML Patients with Imatinib Treatment Failure Poster Presentation, ASH Annual Meeting, 2016.
Impact of Imatinib on Linear Growth and Body Mass Index in Children with Chronic Myeloid Leukemia Poster Presentation, SIOP (International Society of Paediatric Oncology), 2016.
National Conferences
Romiplostim in the Treatment of Primary Immune Thrombocytopenia – An Observational Study Ranjit K. C.S., Ashok K. K., Rajkishore P., Rajesh M. Gottipati, Anil Aribandi Haematocon, Nov 2020.
Use of Monoclonal Antibodies for Hematologic Conditions During COVID-19 Anil Aribandi, Krishnamani K.V., Ranjith Kumar C.S., Arun Lingutla, Ashok Kumar K., Raj Kishore P., Pravallika M.R.P.L. Haematocon, Nov 2020.
Incidence of COVID-19 Infection in Haemato-Oncology Unit in a Non-COVID Hospital Ranjit K. C.S., Rajesh M. Gottipati, Krishnamani K.V., Ashok K. K., Arun Kumar Lingutla, Anil Aribandi Haematocon, Nov 2020.
Decitabine in Elderly AML – The Road Less Travelled Platform Presentation, Haematocon, 2014.
Clinical Profile of RCC – Results from a Tertiary Care Centre Poster Presentation, SAARC Oncology Conference, 2014.
Clinical Profile of RCC – Results from a Tertiary Care Centre Poster Presentation, SAARC Oncology Conference, 2014.
First Case of Allogeneic Stem Cell Transplant in a Low-Resource Setting for Aplastic Anemia Presented at IACMCON, 2010.
Early Career Presentations
A Case Report of Hepatic Amyloidosis Platform Presentation, GECON, 2009.
A Patient Presenting with Polyuria and Polydipsia Poster Presentation, APICON, 2010.
A Case Report of Cryptococcal Septicemia in an HIV Patient Poster Presentation, ASICON, 2010.
Performance of APACHE II in Estimating Mortality Risk in Critically Ill Patients with Infections Admitted to Acute Medical Care Platform Presentation, APICON, 2011.
Patients visit Dr.Ashok Kumar to receive treatment for various blood related cancerous and noncancerous conditions.
Dr.Ashok Kumar holds the following qualifications: MBBS, DNB(NIMS), DM (NIMS) PDF (BMT) (CMC-Vellore)
Dr.Ashok Kumar is a Senior Consultant (Hemato-oncology) and BMT Physician specialised in the treatment of various cancerous and noncancerous blood related conditions.
Dr.Ashok Kumar practices at Yashoda Hospitals, Somajiguda.
You can schedule an appointment with Dr.Ashok Kumar for both an Online Video Consultation and an OPD Consultation by visiting his profile on Yashoda Hospitals.
Appointment
Second Opinion
Live Chat
Call
More
